ArticleAnnals of internal medicine2020

In cancer-associated VTE, apixaban was noninferior to dalteparin for recurrence and did not increase major bleeding.

Irbaz Bin Riaz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.